Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | (1) | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Masimo Corporation | MASI | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 133.85 | 03:05:19 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 133.85 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 75.22 - 167.035 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 133.85 | USD |
Masimo Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.08B | 52.91M | - | 2.05B | 81.5M | 1.54 | 86.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Masimo News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MASI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 124.92 | 134.67 | 122.90 | 129.67 | 692,782 | 8.93 | 7.15% |
| 1 Month | 120.70 | 134.67 | 114.46 | 126.84 | 813,391 | 13.15 | 10.89% |
| 3 Months | 132.92 | 153.93 | 112.85 | 130.25 | 680,714 | 0.93 | 0.70% |
| 6 Months | 113.00 | 153.93 | 107.57 | 127.35 | 661,672 | 20.85 | 18.45% |
| 1 Year | 161.00 | 167.035 | 75.22 | 113.95 | 814,785 | -27.15 | -16.86% |
| 3 Years | 221.05 | 305.21 | 75.22 | 144.78 | 655,688 | -87.20 | -39.45% |
| 5 Years | 144.77 | 305.21 | 75.22 | 162.26 | 547,807 | -10.92 | -7.54% |
Masimo Description
| Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue globally, with the United States the largest market (67% of 2020 sales), followed by Europe, the Middle East, and Africa (21%), Asia and Australia (9%), and North and South America excluding the U.S. (3%). |
